Santen Pharmaceutical Co (Santen Pharmaceutical Co) Change In Inventory : $-57 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co Change In Inventory?

Santen Pharmaceutical Co's change in inventory for the quarter that ended in Dec. 2023 was $-11 Mil. It means Santen Pharmaceutical Co's inventory increased by $11 Mil from Sep. 2023 to Dec. 2023 .

Santen Pharmaceutical Co's change in inventory for the fiscal year that ended in Mar. 2023 was $-9 Mil. It means Santen Pharmaceutical Co's inventory increased by $9 Mil from Mar. 2022 to Mar. 2023 .

Santen Pharmaceutical Co's Total Inventories for the quarter that ended in Dec. 2023 was $326 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Santen Pharmaceutical Co's Days Inventory for the quarter that ended in Dec. 2023 was 129.58.

Inventory Turnover measures how fast the company turns over its inventory within a year. Santen Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.70.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Santen Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.59.

Santen Pharmaceutical Co Change In Inventory Historical Data

The historical data trend for Santen Pharmaceutical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Change In Inventory Chart

Santen Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Inventory

Get a 7-Day Free Trial

-44.99

-9.11

-42.23

45.40

-8.56

Santen Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															13.89	-13.13	-12.08	-20.74	-11.00

Santen Pharmaceutical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-57 Mil.

Santen Pharmaceutical Co (OTCPK:SNPHY) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Santen Pharmaceutical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	317.0585	/	223.264	*	365 / 4
	=	129.58

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Santen Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	223.264	/	317.0585
	=	0.70

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Santen Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	317.0585	/	534.978
	=	0.59

Santen Pharmaceutical Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHY) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

SNPHF:USA 4536:Japan SZD:Germany

Address

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552

Website

http://www.santen.co.jp

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Headlines

From GuruFocus

Matthews Japan Fund 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood • 04-23-2020

Matthews Japan Fund Comments on Santen Pharmaceutical

By Sydnee Gatewood Sydnee Gatewood • 04-23-2020